Why two tests run together
Cervical screening looks for changes caused by persistent high-risk human papillomavirus infection. The Pap (cytology) test examines cervical cells under a microscope for abnormal morphology, while the HPV test detects the viral DNA or RNA of high-risk types such as 16 and 18. Co-testing combines both, catching disease the other might miss.
Most HPV infections clear on their own within one to two years. Screening matters because a small fraction persist and can slowly drive precancerous change over many years, leaving a long window to intervene before cancer develops.
From result to next step
Cytology results are reported using the Bethesda system, with categories such as ASC-US, LSIL, and HSIL describing increasing degrees of abnormality. A positive high-risk HPV result, or higher-grade cytology, can trigger referral for colposcopy, where the cervix is examined under magnification and biopsies may be taken.
Recommended screening intervals and starting ages differ by country and guideline and change over time, so they are not fixed rules. This is general educational information, not medical advice; follow the screening schedule and follow-up advised by your own clinician.